Mount Sinai is a leader in the nation in the research of immune deficiency diseases and the design of innovative treatments. Patients come to Mount Sinai’s Division of Clinical Immunology from across the country for the diagnosis, treatment and therapies of these immune disorders. For this, the division provides: consultations, skin and allergy tests, pulmonary function procedures, examination of antibodies and cell functions, and genetic analysis.
Following the merger, the Division of Clinical Immunology is now poised to become the largest provider of allergy and immunological care in New York City and a destination location for both clinical care of allergies and research in immunotherapy throughout the Mount Sinai Health System.
The Division of Clinical Immunology conducts basic, translational and clinical research aimed at understanding the complex interplay of molecules, cells, tissues, and organs that mobilize to overcome invaders.